Avacta Notes Positive Development Progress For Affirmers
LONDON (Alliance News) - Avacta Group Thursday said it has achieved certain technical milestones towards commercial progress regarding its commercialisation of Affirmer reagents for life sciences research. Affimer reagents are engineered alternatives to antibodies designed to address many o Read More